ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic...
9 insider purchases on record · latest filing 2023-06-05.
Insiders have also filed 23 sale transactions at IBRX.